Global Pharmaceutical CDMO Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201040191 | Category: Medical Care | Pages: 101 | Format: PDF | Published Date: July 11,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Pharmaceutical CDMO Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pharmaceutical CDMO Services market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Innovative Medicine accounting for  % of the Pharmaceutical CDMO Services global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Drug Substance Development and Manufacturing segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Pharmaceutical CDMO Services include Recipharm AB, AMRI Global, Patheon N.V., Aenova Group, and Catalent, Inc., etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Pharmaceutical CDMO Services market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Drug Substance Development and Manufacturing
    Specialized Services
    Lab-based Services
Market segment by Application, can be divided into
    Innovative Medicine
    Patented Drug
    Patent Expired Drug
Market segment by players, this report covers
    Recipharm AB
    AMRI Global
    Patheon N.V.
    Aenova Group
    Catalent, Inc.
    Amatsigroup
    WuXi AppTec Group
    Strides Pharma Science Limited
    Piramal Pharma Solutions
    Siegfried Ltd
    Fareva Group
    FAMAR Health Care Services
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Pharmaceutical CDMO Services product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Pharmaceutical CDMO Services, with revenue, gross margin and global market share of Pharmaceutical CDMO Services from 2019 to 2022.
Chapter 3, the Pharmaceutical CDMO Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pharmaceutical CDMO Services market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Pharmaceutical CDMO Services research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Pharmaceutical CDMO Services
    1.2 Classification of Pharmaceutical CDMO Services by Type
        1.2.1 Overview: Global Pharmaceutical CDMO Services Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2021
        1.2.3 Drug Substance Development and Manufacturing
        1.2.4 Specialized Services
        1.2.5 Lab-based Services
    1.3 Global Pharmaceutical CDMO Services Market by Application
        1.3.1 Overview: Global Pharmaceutical CDMO Services Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Innovative Medicine
        1.3.3 Patented Drug
        1.3.4 Patent Expired Drug
    1.4 Global Pharmaceutical CDMO Services Market Size & Forecast
    1.5 Global Pharmaceutical CDMO Services Market Size and Forecast by Region
        1.5.1 Global Pharmaceutical CDMO Services Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Pharmaceutical CDMO Services Market Size by Region, (2017-2022)
        1.5.3 North America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.4 Europe Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.6 South America Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Pharmaceutical CDMO Services Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Pharmaceutical CDMO Services Market Drivers
        1.6.2 Pharmaceutical CDMO Services Market Restraints
        1.6.3 Pharmaceutical CDMO Services Trends Analysis
2 Company Profiles
    2.1 Recipharm AB
        2.1.1 Recipharm AB Details
        2.1.2 Recipharm AB Major Business
        2.1.3 Recipharm AB Pharmaceutical CDMO Services Product and Solutions
        2.1.4 Recipharm AB Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Recipharm AB Recent Developments and Future Plans
    2.2 AMRI Global
        2.2.1 AMRI Global Details
        2.2.2 AMRI Global Major Business
        2.2.3 AMRI Global Pharmaceutical CDMO Services Product and Solutions
        2.2.4 AMRI Global Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 AMRI Global Recent Developments and Future Plans
    2.3 Patheon N.V.
        2.3.1 Patheon N.V. Details
        2.3.2 Patheon N.V. Major Business
        2.3.3 Patheon N.V. Pharmaceutical CDMO Services Product and Solutions
        2.3.4 Patheon N.V. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Patheon N.V. Recent Developments and Future Plans
    2.4 Aenova Group
        2.4.1 Aenova Group Details
        2.4.2 Aenova Group Major Business
        2.4.3 Aenova Group Pharmaceutical CDMO Services Product and Solutions
        2.4.4 Aenova Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Aenova Group Recent Developments and Future Plans
    2.5 Catalent, Inc.
        2.5.1 Catalent, Inc. Details
        2.5.2 Catalent, Inc. Major Business
        2.5.3 Catalent, Inc. Pharmaceutical CDMO Services Product and Solutions
        2.5.4 Catalent, Inc. Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Catalent, Inc. Recent Developments and Future Plans
    2.6 Amatsigroup
        2.6.1 Amatsigroup Details
        2.6.2 Amatsigroup Major Business
        2.6.3 Amatsigroup Pharmaceutical CDMO Services Product and Solutions
        2.6.4 Amatsigroup Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Amatsigroup Recent Developments and Future Plans
    2.7 WuXi AppTec Group
        2.7.1 WuXi AppTec Group Details
        2.7.2 WuXi AppTec Group Major Business
        2.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Product and Solutions
        2.7.4 WuXi AppTec Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 WuXi AppTec Group Recent Developments and Future Plans
    2.8 Strides Pharma Science Limited
        2.8.1 Strides Pharma Science Limited Details
        2.8.2 Strides Pharma Science Limited Major Business
        2.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Product and Solutions
        2.8.4 Strides Pharma Science Limited Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Strides Pharma Science Limited Recent Developments and Future Plans
    2.9 Piramal Pharma Solutions
        2.9.1 Piramal Pharma Solutions Details
        2.9.2 Piramal Pharma Solutions Major Business
        2.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Product and Solutions
        2.9.4 Piramal Pharma Solutions Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Piramal Pharma Solutions Recent Developments and Future Plans
    2.10 Siegfried Ltd 
        2.10.1 Siegfried Ltd Details
        2.10.2 Siegfried Ltd Major Business
        2.10.3 Siegfried Ltd Pharmaceutical CDMO Services Product and Solutions
        2.10.4 Siegfried Ltd Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Siegfried Ltd Recent Developments and Future Plans
    2.11 Fareva Group
        2.11.1 Fareva Group Details
        2.11.2 Fareva Group Major Business
        2.11.3 Fareva Group Pharmaceutical CDMO Services Product and Solutions
        2.11.4 Fareva Group Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Fareva Group Recent Developments and Future Plans
    2.12 FAMAR Health Care Services
        2.12.1 FAMAR Health Care Services Details
        2.12.2 FAMAR Health Care Services Major Business
        2.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Product and Solutions
        2.12.4 FAMAR Health Care Services Pharmaceutical CDMO Services Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 FAMAR Health Care Services Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Pharmaceutical CDMO Services Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Pharmaceutical CDMO Services Players Market Share in 2021
        3.2.2 Top 10 Pharmaceutical CDMO Services Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Pharmaceutical CDMO Services Players Head Office, Products and Services Provided
    3.4 Pharmaceutical CDMO Services Mergers & Acquisitions
    3.5 Pharmaceutical CDMO Services New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2017-2022)
    4.2 Global Pharmaceutical CDMO Services Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Pharmaceutical CDMO Services Revenue Market Share by Application (2017-2022)
    5.2 Global Pharmaceutical CDMO Services Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    6.2 North America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    6.3 North America Pharmaceutical CDMO Services Market Size by Country
        6.3.1 North America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        6.3.2 United States Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        6.3.3 Canada Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        6.3.4 Mexico Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    7.2 Europe Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    7.3 Europe Pharmaceutical CDMO Services Market Size by Country
        7.3.1 Europe Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        7.3.2 Germany Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.3 France Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.5 Russia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        7.3.6 Italy Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    8.2 Asia-Pacific Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region
        8.3.1 Asia-Pacific Pharmaceutical CDMO Services Revenue by Region (2017-2028)
        8.3.2 China Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.3 Japan Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.4 South Korea Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.5 India Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        8.3.7 Australia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    9.2 South America Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    9.3 South America Pharmaceutical CDMO Services Market Size by Country
        9.3.1 South America Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        9.3.2 Brazil Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        9.3.3 Argentina Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Type (2017-2028)
    10.2 Middle East & Africa Pharmaceutical CDMO Services Revenue by Application (2017-2028)
    10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country
        10.3.1 Middle East & Africa Pharmaceutical CDMO Services Revenue by Country (2017-2028)
        10.3.2 Turkey Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
        10.3.4 UAE Pharmaceutical CDMO Services Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Pharmaceutical CDMO Services Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?